DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 2,074 filers reported holding DANAHER CORPORATION in Q4 2022. The put-call ratio across all filers is 1.10 and the average weighting 0.6%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $4,974,405 | +21.3% | 20,050 | +17.3% | 2.00% | +21.2% |
| Q2 2023 | $4,102,560 | -20.4% | 17,094 | -16.4% | 1.65% | -28.5% |
| Q1 2023 | $5,152,202 | -7.1% | 20,442 | -2.1% | 2.31% | -11.6% |
| Q4 2022 | $5,544,093 | +0.6% | 20,888 | -2.1% | 2.61% | -2.9% |
| Q3 2022 | $5,510,000 | +5.3% | 21,334 | +3.3% | 2.69% | +21.6% |
| Q2 2022 | $5,234,000 | -16.5% | 20,644 | -3.4% | 2.21% | +13.0% |
| Q1 2022 | $6,271,000 | -9.2% | 21,378 | +1.8% | 1.96% | -1.6% |
| Q4 2021 | $6,907,000 | +11.4% | 20,994 | +3.0% | 1.99% | -1.4% |
| Q3 2021 | $6,202,000 | +13.4% | 20,373 | -0.0% | 2.02% | +14.7% |
| Q2 2021 | $5,469,000 | +23.0% | 20,379 | +3.1% | 1.76% | +3.5% |
| Q1 2021 | $4,448,000 | +6.5% | 19,761 | +5.1% | 1.70% | +5.7% |
| Q4 2020 | $4,176,000 | +3.9% | 18,799 | -17.6% | 1.61% | -9.3% |
| Q3 2020 | $4,020,000 | +22.0% | 22,812 | +22.4% | 1.77% | +6.3% |
| Q2 2020 | $3,296,000 | +39.0% | 18,637 | +8.8% | 1.66% | -9.7% |
| Q1 2020 | $2,372,000 | -16.2% | 17,135 | -7.0% | 1.84% | +13.1% |
| Q4 2019 | $2,829,000 | – | 18,431 | – | 1.63% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ARTHUR M. COHEN & ASSOCIATES, LLC | 241,441 | $70,822,000 | 14.94% |
| Defender Capital, LLC. | 143,752 | $42,381,000 | 14.74% |
| Third Point | 2,490,000 | $730,392,000 | 9.51% |
| Riverstone Advisors, LLC | 63,015 | $18,484,000 | 9.49% |
| 11 Capital Partners LP | 96,063 | $28,178,000 | 8.99% |
| Eos Focused Equity Management, L.P. | 34,026 | $9,981,000 | 8.54% |
| CORTLAND ASSOCIATES INC/MO | 187,609 | $55,031,000 | 7.01% |
| Mirova US LLC | 1,242,440 | $364,444,000 | 7.00% |
| Front Street Capital Management, Inc. | 118,397 | $34,729,000 | 6.47% |
| Alphinity Investment Management Pty Ltd | 909,181 | $266,690,000 | 6.21% |